TC-S 7005

CAS No. 1082739-92-1

TC-S 7005 ( —— )

Catalog No. M26838 CAS No. 1082739-92-1

TC-S 7005 is an inhibitor of Polo-like kinases (IC50s: 4 nM, 24 nM and 214 nM for Plk2, Plk3, and Plk1, respectively).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 158 Get Quote
5MG 267 Get Quote
10MG 399 Get Quote
25MG 646 Get Quote
50MG 888 Get Quote
100MG 1197 Get Quote
500MG 2403 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    TC-S 7005
  • Note
    Research use only, not for human use.
  • Brief Description
    TC-S 7005 is an inhibitor of Polo-like kinases (IC50s: 4 nM, 24 nM and 214 nM for Plk2, Plk3, and Plk1, respectively).
  • Description
    TC-S 7005 is an inhibitor of Polo-like kinases (IC50s: 4 nM, 24 nM and 214 nM for Plk2, Plk3, and Plk1, respectively).(In Vitro):In human SR fibroblasts, TC-S 7005(1 μM) obviously causess myofibroblast differentiation and decrease fibroblast proliferation rates .
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    PLK
  • Recptor
    CBP/p300; Cereblon
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1082739-92-1
  • Formula Weight
    359.4
  • Molecular Formula
    C21H17N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[C@H](Nc1cc2c(noc2cn1)-c1ccc2OCOc2c1)c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Raghu Vannam, et al. Targeted degradation of the enhancer lysine acetyltransferases CBP and p300. Cell Chem Biol. 2020 Dec 31;S2451-9456(20)30513-4.
molnova catalog
related products
  • GSK-461364

    A potent, selective, and reversible ATP-competitive PLK1 inhibitor with Ki of 2.2 nM.

  • LDC1267

    LDC1267 is a excellently specific TAM(Tyro3, Axl and Mer) kinase inhibitor, for Mer( IC50<5 nM), Tyro3(IC50=8 nM), and Axl(IC50=29 nM).

  • RO 3280

    RO3280 is a potent, highly selective inhibitor of Polo-like kinase 1 (PLK1)